gentian violet has been researched along with Breast Neoplasms in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vikulina, T; Weitzmann, MN; Yamaguchi, M | 1 |
| Gaffney, C; Gollins, S; Slade, S; Swindell, R | 1 |
| Joubert, A; Stander, A; Vorster, C | 1 |
| Debbert, SL; Hall, DJ; Schimler, SD | 1 |
| Hanes, CM; Lapp, CA; Lewis, JB; Schafer, TE; Schuster, GS; Wataha, JC | 1 |
| Bernhardt, G; Birnböck, H; Reile, H; Schönenberger, H; Spruss, T | 1 |
| Abe, R | 1 |
| Eppenberger, U; Kueng, W; Silber, E | 1 |
1 trial(s) available for gentian violet and Breast Neoplasms
| Article | Year |
|---|---|
RCT on gentian violet versus a hydrogel dressing for radiotherapy-induced moist skin desquamation.
Topics: Aged; Anti-Infective Agents, Local; Bandages, Hydrocolloid; Breast Neoplasms; Clinical Nursing Research; Female; Gentian Violet; Head and Neck Neoplasms; Humans; Male; Middle Aged; Nursing Assessment; Proportional Hazards Models; Prospective Studies; Radiodermatitis; Radiotherapy Dosage; Skin Care; Statistics, Nonparametric; Time Factors; Treatment Outcome; Wound Healing | 2008 |
7 other study(ies) available for gentian violet and Breast Neoplasms
| Article | Year |
|---|---|
Gentian violet inhibits MDA-MB-231 human breast cancer cell proliferation, and reverses the stimulation of osteoclastogenesis and suppression of osteoblast activity induced by cancer cells.
Topics: Animals; Bone Marrow Cells; Bone Resorption; Breast Neoplasms; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Coculture Techniques; Female; Gentian Violet; Humans; Mice; Osteoblasts; Osteoclasts; Xenograft Model Antitumor Assays | 2015 |
Differential signaling involved in Sutherlandia frutescens-induced cell death in MCF-7 and MCF-12A cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Autophagy; Biological Transport; Breast Neoplasms; Cell Line; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Fabaceae; Female; Gentian Violet; Humans; Phosphatidylserines; Plant Extracts; Signal Transduction; South Africa | 2012 |
Anticancer (hexacarbonyldicobalt)propargyl aryl ethers: synthesis, antiproliferative activity, apoptosis induction, and effect on cellular oxidative stress.
Topics: Alkynes; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Membrane Permeability; Cell Proliferation; Cobalt; Ethers; Female; Flow Cytometry; Gentian Violet; Humans; Inhibitory Concentration 50; Oxidative Stress; S Phase; Structure-Activity Relationship | 2013 |
Estrogenicity of bisphenol A and bisphenol A dimethacrylate in vitro.
Topics: Benzhydryl Compounds; Breast Neoplasms; Cell Division; Cell Line; Estradiol; Estrogens, Non-Steroidal; Flow Cytometry; Gentian Violet; Humans; Methacrylates; Phenols; Receptors, Steroid; Rhodamines; Rosaniline Dyes; Tumor Cells, Cultured | 1999 |
Standardized kinetic microassay to quantify differential chemosensitivity on the basis of proliferative activity.
Topics: Adenocarcinoma; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Cell Division; Cisplatin; Diethylstilbestrol; Drug Screening Assays, Antitumor; Female; Fluorouracil; Gentian Violet; Humans; Kinetics; Melphalan; Neoplasms, Hormone-Dependent; Receptors, Estrogen; Receptors, Progesterone; Tumor Cells, Cultured; Vinblastine | 1992 |
The operative management of intraductal papilloma of the breast.
Topics: Breast; Breast Neoplasms; Dissection; Female; Gentian Violet; Humans; Neoplasms, Multiple Primary; Nipples; Papilloma | 1990 |
Quantification of cells cultured on 96-well plates.
Topics: Breast Neoplasms; Cell Count; Gentian Violet; Humans; Tumor Cells, Cultured | 1989 |